TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Beactica Therapeutics AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
666
|
660
|
437 |
Financial expenses |
10
![]() |
10
|
14 |
Earnings before taxes |
-813
|
-957
|
-997 |
EBITDA |
-788
|
-929
|
-931 |
Total assets |
2,701
|
3,280
|
2,771 |
Current assets |
385
|
1,157
|
648 |
Current liabilities |
213
|
388
|
474 |
Equity capital |
2,444
|
2,798
|
2,122 |
- share capital |
32
|
30
|
29 |
Employees (average) |
9
|
8
![]() |
8 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
90.5%
|
85.3%
|
76.6% |
Turnover per employee |
74
|
82
|
55 |
Profit as a percentage of turnover |
-122.1%
|
-145.0%
|
-228.1% |
Return on assets (ROA) |
-29.7%
|
-28.9%
|
-35.5% |
Current ratio |
180.8%
|
298.2%
|
136.7% |
Return on equity (ROE) |
-33.3%
|
-34.2%
|
-47.0% |
Change turnover |
4
|
258
|
149 |
Change turnover % |
1%
|
64%
|
52% |
Chg. No. of employees |
1
|
0
![]() |
0 |
Chg. No. of employees % |
13%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.